President Biden intends to appoint six members to the National Cancer Advisory Board.
What will happen to biomedical research and health care in the aftermath of the 2024 election? The differences in outcomes couldn’t be more stark.
Biden appoints six members to NCAB
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
YOU MAY BE INTERESTED IN
Cancer centers that continue to experience pandemic-induced shortages in staffing their clinical research enterprise may soon be able to rely on support from NCI’s Virtual Clinical Trials Office to open studies and accrue patients.
President Joe Biden has requested an increase of $871.5 million to the overall NIH budget in FY25. Of that amount, $522 million, or nearly 60%, is slated for NCI.
Source: White HouseIn a fiery State of the Union speech designed to showcase his performance as a veteran politician, President Joe Biden leaned into his accomplishments in health care.
We were thrilled to get “the call” from First Lady Jill Biden’s staff.
As the likelihood of a flat budget increases for the 2024 fiscal year, NCI will have difficulty maintaining its current programs, the institute’s new director Kimryn Rathmell said in her inaugural NCI director’s report to members of the National Cancer Advisory Board Feb. 8.
